DarioHealth Corp.
DRIOdata completeness 100%14 fiscal years on fileDarioHealth Corp. earns about -76% on invested capital, and has bought back 76% of its shares over 5 years. The cash-flow models don't apply cleanly here — the ledger says why below.Whether it’s worth owning at today’s price is the last question — and yours to answer, below.
| Figure | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 |
|---|---|---|---|---|---|
| Revenue | $20.5M1 | $27.7M2 | $20.4M3 | $27M4 | $22.4M4 |
| Net income | −$76.8M5 | −$62.2M6 | −$59.4M7 | −$42.7M8 | −$41.7M8 |
| Operating cash flow | −$50.4M9 | −$47.8M10 | −$30.4M11 | −$38.6M12 | −$25.9M12 |
| Capital expenditure | $261,00013 | $442,00014 | $584,00015 | $138,00016 | $142,00016 |
| Free cash flow (derived) | −$50.7M9 | −$48.3M10 | −$31M11 | −$38.7M12 | −$26.1M12 |
| Total debt | $017 | $35.8M18 | $28.5M19 | $28.9M20 | $30.7M20 |
| Cash & equivalents | $35.8M21 | $49.4M22 | $36.8M23 | $27.8M24 | $21.8M24 |
| Diluted shares | 16.6M | 23.6M | 28.4M | 2.5M | 4.0M |
Superscripts are receipts. Each links to the SEC filing the number came from (full list at the bottom).
10 shares is a claim on $170.53 of net worth that earned you −$104.73 and generated −$65.49 of cash last year, against $77.2 of debt.
It earned an average -76% on invested capital over 5 years. Compare that to what it costs to fund the business.
seeing a moat in the numbers →Share count is down 76% over 5 years — management has been buying back stock, quietly handing owners a bigger slice.
reading capital allocation →Signals, not verdicts — read from the filings above. Numbers don’t prove a moat; they show its footprint. You decide.
assumptions (1)
- grahamMultiplier2250.0%
Different models answer different questions — which to trust when →
- 10-K · period ending 2021-12-31 · accession 0001558370-23-003240 (RevenueFromContractWithCustomerIncludingAssessedTax)
- 10-K · period ending 2022-12-31 · accession 0001558370-24-004151 (RevenueFromContractWithCustomerIncludingAssessedTax)
- 10-K · period ending 2023-12-31 · accession 0001558370-25-002527 (RevenueFromContractWithCustomerIncludingAssessedTax)
- 10-K · period ending 2024-12-31 · accession 0001104659-26-031621 (RevenueFromContractWithCustomerIncludingAssessedTax)
- 10-K · period ending 2021-12-31 · accession 0001558370-23-003240 (NetIncomeLoss)
- 10-K · period ending 2022-12-31 · accession 0001558370-24-004151 (NetIncomeLoss)
- 10-K · period ending 2023-12-31 · accession 0001558370-25-002527 (NetIncomeLoss)
- 10-K · period ending 2024-12-31 · accession 0001104659-26-031621 (NetIncomeLoss)
- 10-K · period ending 2021-12-31 · accession 0001558370-23-003240 (NetCashProvidedByUsedInOperatingActivities)
- 10-K · period ending 2022-12-31 · accession 0001558370-24-004151 (NetCashProvidedByUsedInOperatingActivities)
- 10-K · period ending 2023-12-31 · accession 0001558370-25-002527 (NetCashProvidedByUsedInOperatingActivities)
- 10-K · period ending 2024-12-31 · accession 0001104659-26-031621 (NetCashProvidedByUsedInOperatingActivities)
- 10-K · period ending 2021-12-31 · accession 0001558370-23-003240 (PaymentsToAcquirePropertyPlantAndEquipment)
- 10-K · period ending 2022-12-31 · accession 0001558370-24-004151 (PaymentsToAcquirePropertyPlantAndEquipment)
- 10-K · period ending 2023-12-31 · accession 0001558370-25-002527 (PaymentsToAcquirePropertyPlantAndEquipment)
- 10-K · period ending 2024-12-31 · accession 0001104659-26-031621 (PaymentsToAcquirePropertyPlantAndEquipment)
- 10-K · period ending 2021-12-31 · accession 0001558370-23-003240 (LongTermDebtNoncurrent)
- 10-K · period ending 2022-12-31 · accession 0001558370-24-004151 (LongTermDebtNoncurrent)
- 10-K · period ending 2023-12-31 · accession 0001558370-25-002527 (LongTermDebtNoncurrent)
- 10-K · period ending 2024-12-31 · accession 0001104659-26-031621 (LongTermDebtNoncurrent)
- 10-K · period ending 2021-12-31 · accession 0001558370-23-003240 (CashAndCashEquivalentsAtCarryingValue)
- 10-K · period ending 2022-12-31 · accession 0001558370-24-004151 (CashAndCashEquivalentsAtCarryingValue)
- 10-K · period ending 2023-12-31 · accession 0001558370-25-002527 (CashAndCashEquivalentsAtCarryingValue)
- 10-K · period ending 2024-12-31 · accession 0001104659-26-031621 (CashAndCashEquivalentsAtCarryingValue)